1. Home
  2. WIMI vs NRSN Comparison

WIMI vs NRSN Comparison

Compare WIMI & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WiMi Hologram Cloud Inc.

WIMI

WiMi Hologram Cloud Inc.

HOLD

Current Price

$2.80

Market Cap

31.9M

Sector

Technology

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.84

Market Cap

26.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIMI
NRSN
Founded
2015
2017
Country
China
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.9M
26.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
WIMI
NRSN
Price
$2.80
$0.84
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$14.00
AVG Volume (30 Days)
96.6K
366.2K
Earning Date
12-26-2025
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.43
N/A
Revenue
$61,329,146.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.24
$0.68
52 Week High
$9.66
$2.60

Technical Indicators

Market Signals
Indicator
WIMI
NRSN
Relative Strength Index (RSI) 51.93 46.61
Support Level $2.30 $0.68
Resistance Level $2.65 $0.91
Average True Range (ATR) 0.20 0.07
MACD 0.02 0.01
Stochastic Oscillator 75.32 71.22

Price Performance

Historical Comparison
WIMI
NRSN

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: